A BILL 
To amend chapter 110 of title 18, United States Code, 
to prohibit gender reassignment medical interventions on 
minors, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Protecting Children 
4
From Experimentation Act of 2021’’. 
5
23:29 May 11, 2021
H1926
2 
•HR 1926 IH
SEC. 2. GENDER REASSIGNMENT MEDICAL INTERVENTIONS 
1
ON MINORS PROHIBITED. 
2
Chapter 110 of title 18, United States Code, is 
3
amended— 
4
(1) by adding at the end the following: 
5
‘‘§ 2260B. Gender reassignment medical interventions 
6
on minors 
7
‘‘(a) IN GENERAL.—Whoever knowingly performs 
8
any gender reassignment medical intervention on a minor 
9
shall be fined under this title or imprisoned not more than 
10
5 years, or both. 
11
‘‘(b) PROHIBITION ON PROSECUTION OF PERSON ON 
12
WHOM INTERVENTION IS PERFORMED.—No person on 
13
whom the gender reassignment medical intervention under 
14
subsection (a) is performed may be arrested or prosecuted 
15
for an offense under this section. 
16
‘‘(c) CIVIL ACTION.—A person on whom a gender re-
17
assignment medical intervention is performed under this 
18
section may bring a civil action for appropriate relief 
19
against each person who performed the gender reassign-
20
ment medical intervention. 
21
‘‘(d) DEFINITIONS.—In this section: 
22
‘‘(1) GENDER REASSIGNMENT MEDICAL INTER-
23
VENTION.— 
24
‘‘(A) IN GENERAL.—For purposes of this 
25
chapter, except as provided in subparagraph 
26
23:29 May 11, 2021
H1926
3 
•HR 1926 IH
(B), the term ‘gender reassignment medical 
1
intervention’ means— 
2
‘‘(i) performing a surgery that steri-
3
lizes an individual, including castration, 
4
vasectomy, hysterectomy, oophorectomy, 
5
metoidioplasty, penectomy, phalloplasty, 
6
and vaginoplasty, to change the body of 
7
such individual to correspond to a sex that 
8
is discordant with biological sex; 
9
‘‘(ii) performing a mastectomy on an 
10
individual for the purpose described in 
11
clause (i); or 
12
‘‘(iii) administering or supplying to an 
13
individual medications for the purpose de-
14
scribed in clause (i), including— 
15
‘‘(I) GnRH agonists or other pu-
16
berty-blocking drugs to stop or delay 
17
normal puberty; 
18
‘‘(II) testosterone or other andro-
19
gens to biological females at doses 
20
that are supraphysiologic to the fe-
21
male sex; or 
22
‘‘(III) 
estrogen 
to 
biological 
23
males at doses that are supraphysio-
24
logic to the male sex. 
25
23:29 May 11, 2021
H1926
4 
•HR 1926 IH
‘‘(B) 
EXCEPTION.—Subparagraph 
(A) 
1
shall not apply to the following individuals: 
2
‘‘(i) An individual with external bio-
3
logical 
sex 
characteristics 
that 
are 
4
irresolvably ambiguous, such as those born 
5
with 46 XX chromosomes with virilization, 
6
46 XY chromosomes with undervirilization, 
7
or having both ovarian and testicular tis-
8
sue. 
9
‘‘(ii) An individual with respect to 
10
whom a physician has determined through 
11
genetic or biochemical testing that the in-
12
dividual does not have normal sex chro-
13
mosome structure, sex steroid hormone 
14
production, or sex steroid hormone action 
15
for a biological male or biological female. 
16
‘‘(2) MINOR.—The term ‘minor’ means any per-
17
son under the age of eighteen years.’’; and 
18
(2) by amending the table of sections for such 
19
chapter by adding at the end the following: 
20
‘‘2260B. Gender reassignment medical interventions on minors.’’. 
Æ 
23:29 May 11, 2021
H1926
